Keywords: Generic drugs; Prescribing rate; Medical dermatology; Medicare Part D EN Generic drugs Prescribing rate Medical dermatology Medicare Part D 2991 2993 3 11/02/23 20231201 NES 231201 Introduction In the United States (U.S.), prescription medication costs have grown substantially, with projections to reach $560 million by 2028 [[1]]. Yet, despite state-level efforts to promote generic drugs (namely through generic substitution laws [[3]]) and estimates of considerable cost savings, state-by-state use of generic drugs in dermatology have not been analyzed. [Extracted from the article]